Ihn 500 Tablet contains Inositol Nicotinate 500 mg, a compound utilized primarily for its vasodilatory and lipid-lowering properties. Inositol Nicotinate is a derivative of niacin (vitamin B3) that functions by enhancing peripheral blood flow through the dilation of small blood vessels, thereby improving microcirculation. It is commonly prescribed in the management of conditions associated with impaired blood flow such as peripheral vascular disease, intermittent claudication, and certain forms of dyslipidemia. The mechanism of action involves the release of nicotinic acid, which promotes the relaxation of vascular smooth muscle and reduces blood viscosity, contributing to improved tissue oxygenation and nutrient delivery. Additionally, Inositol Nicotinate may aid in the reduction of serum cholesterol and triglyceride levels, supporting cardiovascular health. Ihn 500 Tablet is generally well tolerated, with fewer flushing side effects compared to niacin due to its gradual release of nicotinic acid. It should be used under medical supervision, particularly in patients with hepatic or renal impairment, and those on concurrent lipid-lowering therapies. Dosage and duration of treatment should be individualized based on clinical response and tolerability. Regular monitoring of lipid profiles and liver function tests is recommended during prolonged therapy.